Osteoporosis screening: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
==Screening== | ==Screening== | ||
The US Preventive Services Task Force (USPSTF) in 2011 recommended:<ref name="pmid21242341">{{cite journal| author=U.S. Preventive Services Task Force| title=Screening for osteoporosis: U.S. preventive services task force recommendation statement. | journal=Ann Intern Med | year= 2011 | volume= 154 | issue= 5 | pages= 356-64 | pmid=21242341 | doi=10.7326/0003-4819-154-5-201103010-00307 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21242341 }} </ref> | |||
* "screening for osteoporosis in women aged 65 years and older" | |||
* "younger women whose fracture risk is equal to or greater than that of a 65-year old white women who has no additional risk factors." | |||
** This risk is 9.3% 10-year risk for any osteoporotic fracture and can be estimated by the [http://www.shef.ac.uk/FRAX/ FRAX tool]. | |||
* "insufficient to assess the balance of benefits and harms of screening for osteoporosis in men" | |||
Prior USPSTF recommendations from 2002 were: | |||
* All women 65 and older be screened with bone densitometry.<ref name="pmid12230355">{{cite journal |author=U.S. Preventive Services Task Force |title=Screening for osteoporosis in postmenopausal women: recommendations and rationale |journal=Ann. Intern. Med. |volume=137 |issue=6 |pages=526-8|year=2002 |pmid=12230355 |doi=}}</ref> | |||
* The Task Force recommends screening women aged 60 to 64 who are at increased risk. The most significant risk factor for indicating an increased probability of having osteoporosis is lower body weight (weight < 70 kg). | * The Task Force recommends screening women aged 60 to 64 who are at increased risk. The most significant risk factor for indicating an increased probability of having osteoporosis is lower body weight (weight < 70 kg). | ||
* Clinical prediction rules are available to guide selection of women for screening. The Osteoporosis Risk Assessment Instrument (ORAI) may be the most [[sensitivity (tests)|sensitive]] strategy.<ref name="pmid17552058">{{cite journal |author=Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM |title=Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit |journal=J. Rheumatol. |volume=34 |issue=6|pages=1307-12 |year=2007 |pmid=17552058 |doi=}}</ref> The ORAI is available online at http://osteoed.org/tools.php?type=orai. | * Clinical prediction rules are available to guide selection of women for screening. The Osteoporosis Risk Assessment Instrument (ORAI) may be the most [[sensitivity (tests)|sensitive]] strategy.<ref name="pmid17552058">{{cite journal |author=Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM |title=Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit |journal=J. Rheumatol. |volume=34 |issue=6|pages=1307-12 |year=2007 |pmid=17552058 |doi=}}</ref> The ORAI is available online at http://osteoed.org/tools.php?type=orai. | ||
Revision as of 16:44, 8 October 2014
|
Osteoporosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Osteoporosis screening On the Web |
|
American Roentgen Ray Society Images of Osteoporosis screening |
|
Risk calculators and risk factors for Osteoporosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S.[3]
Overview
Osteoporosis is common in people 65 years and older. Bone turnover is unbalanced in elderly individuals, especially in females because of the lack of estrogen after menopause. The US Preventive Services Task Force (USPSTF) recommends that all women 65 and older be screened with a DEXA scan.
Screening
The US Preventive Services Task Force (USPSTF) in 2011 recommended:[1]
- "screening for osteoporosis in women aged 65 years and older"
- "younger women whose fracture risk is equal to or greater than that of a 65-year old white women who has no additional risk factors."
- This risk is 9.3% 10-year risk for any osteoporotic fracture and can be estimated by the FRAX tool.
- "insufficient to assess the balance of benefits and harms of screening for osteoporosis in men"
Prior USPSTF recommendations from 2002 were:
- All women 65 and older be screened with bone densitometry.[2]
- The Task Force recommends screening women aged 60 to 64 who are at increased risk. The most significant risk factor for indicating an increased probability of having osteoporosis is lower body weight (weight < 70 kg).
- Clinical prediction rules are available to guide selection of women for screening. The Osteoporosis Risk Assessment Instrument (ORAI) may be the most sensitive strategy.[3] The ORAI is available online at http://osteoed.org/tools.php?type=orai.
- Regarding the screening of men, a cost-analysis study suggests that screening may be "cost-effective for men with a self-reported prior fracture beginning at age 65 years and for men 80 years and older with no prior fracture".[4]
After an initial screening bone mineral density, optimal intervals to repeat densitometry may be:[5]
- "15 years for women with normal bone density or mild osteopenia (T score, greater than −1.50)"
- "5 years for women with moderate osteopenia (T score, −1.50 to −1.99)"
- "1 year for women with advanced osteopenia (T score, −2.00 to −2.49)"
References
- ↑ U.S. Preventive Services Task Force (2011). "Screening for osteoporosis: U.S. preventive services task force recommendation statement". Ann Intern Med. 154 (5): 356–64. doi:10.7326/0003-4819-154-5-201103010-00307. PMID 21242341.
- ↑ U.S. Preventive Services Task Force (2002). "Screening for osteoporosis in postmenopausal women: recommendations and rationale". Ann. Intern. Med. 137 (6): 526–8. PMID 12230355.
- ↑ Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM (2007). "Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit". J. Rheumatol. 34 (6): 1307–12. PMID 17552058.
- ↑ Schousboe JT, Taylor BC, Fink HA; et al. (2007). "Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men". JAMA. 298 (6): 629–37. doi:10.1001/jama.298.6.629. PMID 17684185.
- ↑ Gourlay ML, Fine JP, Preisser JS, May RC, Li C, Lui LY; et al. (2012). "Bone-density testing interval and transition to osteoporosis in older women". N Engl J Med. 366 (3): 225–33. doi:10.1056/NEJMoa1107142. PMC 3285114. PMID 22256806.